• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.CD8 依赖性抗原识别、T 细胞功能亲和力与肿瘤细胞识别之间的关系。
Cancer Immunol Immunother. 2009 May;58(5):719-28. doi: 10.1007/s00262-008-0594-2. Epub 2008 Oct 3.
2
Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.在给予gp100疫苗后,对识别来自一名黑色素瘤患者的gp100抗原的MHC I类限制性TCRαβ⁺ CD4⁻ CD8⁻双阴性T细胞的特征分析。
Cancer Immunol Immunother. 2009 May;58(5):709-18. doi: 10.1007/s00262-008-0593-3. Epub 2008 Oct 3.
3
Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.将工程化TCRαβ基因转入原代人T淋巴细胞后,抗糖蛋白100细胞毒性T淋巴细胞的肽精细特异性得以保留。
J Immunol. 2003 Feb 15;170(4):2186-94. doi: 10.4049/jimmunol.170.4.2186.
4
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.将高效TCR基因转移到原代人淋巴细胞中可实现对黑色素瘤肿瘤抗原糖蛋白100的强烈识别,且不会改变对自体黑色素瘤抗原的识别。
J Immunol. 2003 Sep 15;171(6):3287-95. doi: 10.4049/jimmunol.171.6.3287.
5
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.使用肽-MHC四聚体从异质群体中分离高亲和力黑色素瘤反应性CTL。
J Immunol. 1999 Feb 15;162(4):2227-34.
6
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.自体黑色素瘤反应性细胞毒性T淋巴细胞(CTL)克隆的T细胞受体(TCR)结构:肿瘤浸润淋巴细胞在体内过度表达一种由HLA - A2限制性且黑色素细胞谱系特异性CTL克隆所使用的TCRβ链序列。
J Exp Med. 1993 Oct 1;178(4):1231-46. doi: 10.1084/jem.178.4.1231.
7
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.抗原特异性肿瘤疫苗。编码MART1或gp100的重组腺病毒用于癌症治疗的研发与特性分析。
J Immunol. 1996 Jan 15;156(2):700-10.
8
Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.在黑素小体蛋白上鉴定由HLA - A1、- A2和- A3等位基因限制的肿瘤浸润性T淋巴细胞所识别的新黑色素瘤表位。
J Immunol. 1998 Dec 15;161(12):6985-92.
9
Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.一种人类细胞毒性T细胞克隆对黑色素瘤抗原的双重识别。
Cancer Res. 1996 May 15;56(10):2368-74.
10
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.与体内肿瘤消退相关的肿瘤浸润性T淋巴细胞对人黑色素瘤抗原gp100中多个表位的识别。
J Immunol. 1995 Apr 15;154(8):3961-8.

引用本文的文献

1
Genetic Modification of T Cells for the Immunotherapy of Cancer.用于癌症免疫治疗的T细胞基因改造
Vaccines (Basel). 2022 Mar 16;10(3):457. doi: 10.3390/vaccines10030457.
2
Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications.癌症纳米药物:物理化学表征及体内外应用
Cancers (Basel). 2021 Apr 15;13(8):1896. doi: 10.3390/cancers13081896.
3
Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.持续调节以稳定 CD8 T 细胞功能亲和力及其对癌症免疫治疗的可能影响。
Eur J Immunol. 2021 Jun;51(6):1348-1360. doi: 10.1002/eji.202049016. Epub 2021 Mar 30.
4
Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner.结构沉默肽锚修饰物以受体依赖性方式变构调节 T 细胞识别。
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi: 10.1073/pnas.2018125118.
5
Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors.预测 T 细胞受体的交叉反应性和抗原特异性。
Front Immunol. 2020 Oct 22;11:565096. doi: 10.3389/fimmu.2020.565096. eCollection 2020.
6
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.鼠源 CD8 T 细胞功能亲和性在体内稳定,但在体外不稳定:与同源初次/加强免疫时间间隔和抗原密度无关。
Eur J Immunol. 2020 Apr;50(4):505-514. doi: 10.1002/eji.201948355. Epub 2019 Dec 10.
7
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.了解 TCR 亲和力、抗原特异性和交叉反应性,以改善用于癌症免疫治疗的 TCR 基因修饰 T 细胞。
Cancer Immunol Immunother. 2019 Nov;68(11):1881-1889. doi: 10.1007/s00262-019-02401-0. Epub 2019 Oct 8.
8
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells.gp100 反应性 T 细胞受体的分子特性驱动转基因宿主 T 细胞的细胞因子谱和抗肿瘤疗效。
Pigment Cell Melanoma Res. 2019 Jan;32(1):68-78. doi: 10.1111/pcmr.12724. Epub 2018 Aug 13.
9
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.关键生物学参数调节亲和力,作为T细胞受体基因修饰T细胞功能的决定因素。
Cancer Immunol Immunother. 2017 Nov;66(11):1411-1424. doi: 10.1007/s00262-017-2032-9. Epub 2017 Jun 20.
10
Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.从白癜风患者皮肤中对gp100反应性T细胞受体进行功能克隆。
Pigment Cell Melanoma Res. 2016 May;29(3):379-84. doi: 10.1111/pcmr.12458. Epub 2016 Mar 4.

本文引用的文献

1
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.人类肿瘤中MHC I类异常和抗原加工与呈递(APM)成分的分子机制。
Cancer Immunol Immunother. 2008 Nov;57(11):1719-26. doi: 10.1007/s00262-008-0515-4. Epub 2008 Apr 12.
2
Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells.钙β界面的分子设计有利于人T细胞中引入的TCRαβ特异性配对。
J Immunol. 2008 Jan 1;180(1):391-401. doi: 10.4049/jimmunol.180.1.391.
3
A T-cell receptor associated with naturally occurring human tumor immunity.一种与自然发生的人类肿瘤免疫相关的T细胞受体。
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19073-8. doi: 10.1073/pnas.0704336104.
4
Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.用癌胚抗原类似物CAP1-6D肽启动的CD8(+) T细胞中TCR亲和力低且缺乏肿瘤细胞识别能力。
Cancer Immunol Immunother. 2007 Dec;56(12):1979-91. doi: 10.1007/s00262-007-0342-z. Epub 2007 Jun 13.
5
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.经工程改造以表达带有第二个二硫键的T细胞受体的T细胞,其抗肿瘤活性增强。
Cancer Res. 2007 Apr 15;67(8):3898-903. doi: 10.1158/0008-5472.CAN-06-3986.
6
Full activation of the T cell receptor requires both clustering and conformational changes at CD3.T细胞受体的完全激活需要CD3处的聚集和构象变化。
Immunity. 2007 Jan;26(1):43-54. doi: 10.1016/j.immuni.2006.10.019. Epub 2006 Dec 21.
7
Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.人CD8对T细胞受体转导细胞抗原识别的影响。
Cancer Res. 2006 Dec 1;66(23):11455-61. doi: 10.1158/0008-5472.CAN-06-2379.
8
Facilitating matched pairing and expression of TCR chains introduced into human T cells.促进引入人T细胞中的TCR链的匹配配对和表达。
Blood. 2007 Mar 15;109(6):2331-8. doi: 10.1182/blood-2006-05-023069. Epub 2006 Nov 2.
9
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.人淋巴细胞中鼠-人杂交T细胞受体(TCR)抗肿瘤活性增强与配对改善及TCR/CD3稳定性提高有关。
Cancer Res. 2006 Sep 1;66(17):8878-86. doi: 10.1158/0008-5472.CAN-06-1450.
10
Cancer regression in patients after transfer of genetically engineered lymphocytes.基因工程淋巴细胞转移后患者的癌症消退。
Science. 2006 Oct 6;314(5796):126-9. doi: 10.1126/science.1129003. Epub 2006 Aug 31.

CD8 依赖性抗原识别、T 细胞功能亲和力与肿瘤细胞识别之间的关系。

Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

作者信息

Moore Tamson V, Lyons Gretchen E, Brasic Natasha, Roszkowski Jeffrey J, Voelkl Simon, Mackensen Andreas, Kast W Martin, Le Poole I Caroline, Nishimura Michael I

机构信息

Department of Surgery, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Cancer Immunol Immunother. 2009 May;58(5):719-28. doi: 10.1007/s00262-008-0594-2. Epub 2008 Oct 3.

DOI:10.1007/s00262-008-0594-2
PMID:18836717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2773431/
Abstract

Effective immunotherapy using T cell receptor (TCR) gene-modified T cells requires an understanding of the relationship between TCR affinity and functional avidity of T cells. In this study, we evaluate the relative affinity of two TCRs isolated from HLA-A2-restricted, gp100-reactive T cell clones with extremely high functional avidity. Furthermore, one of these T cell clones, was CD4- CD8- indicating that antigen recognition by this clone was CD8 independent. However, when these TCRs were expressed in CD8- Jurkat cells, the resulting Jurkat cells recognized gp100:209-217 peptide loaded T2 cells and had high functional avidity, but could not recognize HLA-A2+ melanoma cells expressing gp100. Tumor cell recognition by Jurkat cells expressing these TCRs could not be induced by exogenously loading the tumor cells with the native gp100:209-217 peptide. These results indicate that functional avidity of a T cell does not necessarily correlate with TCR affinity and CD8-independent antigen recognition by a T cell does not always mean its TCR will transfer CD8-independence to other effector cells. The implications of these findings are that T cells can modulate their functional avidity independent of the affinity of their TCRs.

摘要

使用经T细胞受体(TCR)基因修饰的T细胞进行有效的免疫治疗需要了解T细胞的TCR亲和力与功能亲合力之间的关系。在本研究中,我们评估了从具有极高功能亲合力的HLA-A2限制性、gp100反应性T细胞克隆中分离出的两种TCR的相对亲和力。此外,这些T细胞克隆之一为CD4-CD8-,表明该克隆的抗原识别不依赖CD8。然而,当这些TCR在CD8-Jurkat细胞中表达时,产生的Jurkat细胞能够识别负载gp100:209-217肽的T2细胞,并且具有高功能亲合力,但无法识别表达gp100的HLA-A2+黑色素瘤细胞。用天然gp100:209-217肽对外源负载肿瘤细胞,并不能诱导表达这些TCR的Jurkat细胞识别肿瘤细胞。这些结果表明,T细胞的功能亲合力不一定与TCR亲和力相关,并且T细胞的CD8非依赖性抗原识别并不总是意味着其TCR会将CD8非依赖性传递给其他效应细胞。这些发现的意义在于,T细胞可以独立于其TCR的亲和力来调节其功能亲合力。